These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34673825)

  • 1. Inhibition of the H3K27 demethylase UTX enhances the epigenetic silencing of HIV proviruses and induces HIV-1 DNA hypermethylation but fails to permanently block HIV reactivation.
    Nguyen K; Dobrowolski C; Shukla M; Cho WK; Luttge B; Karn J
    PLoS Pathog; 2021 Oct; 17(10):e1010014. PubMed ID: 34673825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency.
    Méndez C; Ledger S; Petoumenos K; Ahlenstiel C; Kelleher AD
    Retrovirology; 2018 Oct; 15(1):67. PubMed ID: 30286764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone demethylase UTX is a therapeutic target for diabetic kidney disease.
    Chen H; Huang Y; Zhu X; Liu C; Yuan Y; Su H; Zhang C; Liu C; Xiong M; Qu Y; Yun P; Zheng L; Huang K
    J Physiol; 2019 Mar; 597(6):1643-1660. PubMed ID: 30516825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EZH2, JMJD3, and UTX epigenetically regulate hepatic plasticity inducing retro-differentiation and proliferation of liver cells.
    Pediconi N; Salerno D; Lupacchini L; Angrisani A; Peruzzi G; De Smaele E; Levrero M; Belloni L
    Cell Death Dis; 2019 Jul; 10(7):518. PubMed ID: 31285428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic silencing of HIV-1 by the histone H3 lysine 27 methyltransferase enhancer of Zeste 2.
    Friedman J; Cho WK; Chu CK; Keedy KS; Archin NM; Margolis DM; Karn J
    J Virol; 2011 Sep; 85(17):9078-89. PubMed ID: 21715480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UTX-1 regulates Tat-induced HIV-1 transactivation via changing the methylated status of histone H3.
    Zhang HS; Du GY; Liu Y; Zhang ZG; Zhou Z; Li H; Dai KQ; Yu XY; Gou XM
    Int J Biochem Cell Biol; 2016 Nov; 80():51-56. PubMed ID: 27671333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host Methyltransferases and Demethylases: Potential New Epigenetic Targets for HIV Cure Strategies and Beyond.
    Boehm D; Ott M
    AIDS Res Hum Retroviruses; 2017 Nov; 33(S1):S8-S22. PubMed ID: 29140109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of H3K27me3-specific histone demethylases JMJD3 and UTX blocks reactivation of herpes simplex virus 1 in trigeminal ganglion neurons.
    Messer HG; Jacobs D; Dhummakupt A; Bloom DC
    J Virol; 2015 Mar; 89(6):3417-20. PubMed ID: 25552720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone demethylase UTX counteracts glucocorticoid deregulation of osteogenesis by modulating histone-dependent and -independent pathways.
    Wang FS; Lian WS; Lee MS; Weng WT; Huang YH; Chen YS; Sun YC; Wu SL; Chuang PC; Ko JY
    J Mol Med (Berl); 2017 May; 95(5):499-512. PubMed ID: 28130569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5' long terminal repeat (LTR)-selective methylation of latently infected HIV-1 provirus that is demethylated by reactivation signals.
    Ishida T; Hamano A; Koiwa T; Watanabe T
    Retrovirology; 2006 Oct; 3():69. PubMed ID: 17034647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the Histone H3K27 Demethylase UTX Enhances Tumor Cell Radiosensitivity.
    Rath BH; Waung I; Camphausen K; Tofilon PJ
    Mol Cancer Ther; 2018 May; 17(5):1070-1078. PubMed ID: 29483212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple Histone Lysine Methyltransferases Are Required for the Establishment and Maintenance of HIV-1 Latency.
    Nguyen K; Das B; Dobrowolski C; Karn J
    mBio; 2017 Feb; 8(1):. PubMed ID: 28246360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A CRISPR/Cas9 screen identifies the histone demethylase MINA53 as a novel HIV-1 latency-promoting gene (LPG).
    Huang H; Kong W; Jean M; Fiches G; Zhou D; Hayashi T; Que J; Santoso N; Zhu J
    Nucleic Acids Res; 2019 Aug; 47(14):7333-7347. PubMed ID: 31165872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG methylation controls reactivation of HIV from latency.
    Blazkova J; Trejbalova K; Gondois-Rey F; Halfon P; Philibert P; Guiguen A; Verdin E; Olive D; Van Lint C; Hejnar J; Hirsch I
    PLoS Pathog; 2009 Aug; 5(8):e1000554. PubMed ID: 19696893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A KDM6 inhibitor potently induces ATF4 and its target gene expression through HRI activation and by UTX inhibition.
    Kitajima S; Sun W; Lee KL; Ho JC; Oyadomari S; Okamoto T; Masai H; Poellinger L; Kato H
    Sci Rep; 2021 Feb; 11(1):4538. PubMed ID: 33633164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of 5' LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individuals.
    Trejbalová K; Kovářová D; Blažková J; Machala L; Jilich D; Weber J; Kučerová D; Vencálek O; Hirsch I; Hejnar J
    Clin Epigenetics; 2016; 8():19. PubMed ID: 26900410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H3K27me3 demethylases regulate in vitro chondrogenesis and chondrocyte activity in osteoarthritis.
    Yapp C; Carr AJ; Price A; Oppermann U; Snelling SJ
    Arthritis Res Ther; 2016 Jul; 18(1):158. PubMed ID: 27388528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma.
    Lochmann TL; Powell KM; Ham J; Floros KV; Heisey DAR; Kurupi RIJ; Calbert ML; Ghotra MS; Greninger P; Dozmorov M; Gowda M; Souers AJ; Reynolds CP; Benes CH; Faber AC
    Sci Transl Med; 2018 May; 10(441):. PubMed ID: 29769286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KDM5A/B contribute to HIV-1 latent infection and survival of HIV-1 infected cells.
    Li TW; Park Y; Watters EG; Wang X; Zhou D; Fiches GN; Wu Z; Badley AD; Sacha JB; Ho WZ; Santoso NG; Qi J; Zhu J
    Antiviral Res; 2024 Aug; 228():105947. PubMed ID: 38925368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevating H3K27me3 level sensitizes colorectal cancer to oxaliplatin.
    Wang Q; Chen X; Jiang Y; Liu S; Liu H; Sun X; Zhang H; Liu Z; Tao Y; Li C; Hu Y; Liu D; Ye D; Liu Y; Wang M; Zhang X
    J Mol Cell Biol; 2020 Feb; 12(2):125-137. PubMed ID: 31065671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.